Dahong Li Selected Research

enmein

2/2018

Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dahong Li Research Topics

Disease

22	Neoplasms (Cancer) 12/2022 - 06/2012
7	Breast Neoplasms (Breast Cancer) 12/2022 - 10/2018
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
3	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2020
3	Triple Negative Breast Neoplasms 12/2021 - 01/2020
2	Hypoxia (Hypoxemia) 09/2021 - 05/2017
2	Prostatic Neoplasms (Prostate Cancer) 06/2021 - 02/2018
2	Leukemia 01/2020 - 02/2018
2	Liver Neoplasms (Liver Cancer) 02/2018 - 07/2017
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Melanoma (Melanoma, Malignant) 06/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2021
1	Leukemia L1210 06/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021
1	Wounds and Injuries (Trauma) 02/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Pathologic Processes 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2019
1	Obesity 12/2018
1	Diabetes Mellitus 08/2018
1	Cardiomyopathies (Cardiomyopathy) 08/2018
1	Osteoporosis 08/2018
1	Diabetes Complications 08/2018
1	Insulin Resistance 08/2018
1	Stomach Neoplasms (Stomach Cancer) 06/2012

Drug/Important Bio-Agent (IBA)

11	oridoninIBA 01/2020 - 06/2012
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2021 - 01/2020
3	Biological ProductsIBA 01/2019 - 06/2012
2	Mechlorethamine (Nitrogen Mustard)FDA Link 12/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 08/2016
2	1,2,5-oxadiazole 2-oxideIBA 01/2021 - 06/2012
2	Carbolines (Beta-Carbolines)IBA 01/2021 - 01/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020 - 06/2012
2	DiterpenesIBA 02/2018 - 01/2013
1	ChromonesIBA 12/2022
1	sinomenineIBA 12/2022
1	Phosphotransferases (Kinase)IBA 06/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2022
1	p21-Activated KinasesIBA 06/2022
1	evodiamineIBA 12/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2021
1	NitroreductasesIBA 09/2021
1	Immunoconjugates (Immunoconjugate)IBA 06/2021
1	SilverIBA 05/2021
1	Therapeutic UsesIBA 05/2021
1	Sincalide FDA Link 01/2021
1	GasotransmittersIBA 02/2020
1	Carbon MonoxideIBA 02/2020
1	chelidonineIBA 01/2020
1	IntegrinsIBA 01/2020
1	HAO472IBA 01/2020
1	EstersIBA 06/2019
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 12/2018
1	LipidsIBA 08/2018
1	Silybin (Lagosa)IBA 08/2018
1	Cytochromes c (Cytochrome c)IBA 02/2018
1	Caspase 3 (Caspase-3)IBA 02/2018
1	enmeinIBA 02/2018
1	DAPIIBA 11/2017
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 11/2017
1	Annexin A5IBA 11/2017
1	Antineoplastic Agents (Antineoplastics)IBA 07/2017
1	scutellarinIBA 07/2017
1	NAD (NADH)IBA 05/2017
1	ProdrugsIBA 05/2017
1	EnzymesIBA 05/2017
1	Oxidoreductases (Dehydrogenase)IBA 05/2017
1	quinone (benzoquinone)IBA 05/2017
1	Kaurane DiterpenesIBA 01/2017
1	LactonesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 08/2016
1	Antimutagenic Agents (Antimutagens)IBA 08/2016
1	Proteins (Proteins, Gene)FDA Link 08/2016
1	NitrogenIBA 07/2014
1	compound 17IBA 06/2013
1	CaspasesIBA 06/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2013
1	kaureneIBA 01/2013

Therapy/Procedure

6	Therapeutics 05/2021 - 01/2017
1	Topical Administration 02/2020